The low cardiac output syndrome is a major hazard of the early postoperative period after open-heart surgery, and its onset is associated with a high mortality. Correction of hypovolaemia and the counteraction of depressed left ventricular function by inotropic agents and vasodilator drugs have greatly improved the outlook, but some patients still fail to respond adequately to these measures. The primary fault is one of pumping failure of the heart, and in this respect it is similar to the heart failure associated with naturally occurring disease. The pumping failure associated with cardiogenic shock after myocardial infarction and that associated with severe congestive heart failure have both been found to be accompanied by suppression of insulin secretion (Taylor et al., I969; Sharma et al., 1970) . The following investigation was, therefore, designed to measure the facility with which insulin was released in patients undergoing open-heart operations for valve replacement.
Subjects and methods
Clinical details Six patients undergoing openheart surgery for mitral or aortic valve replaceReceived 25 February 1970. 1 Requests for reprints should be addressed to S. H. Taylor, Department of Medicine, The General Infirmary, Leeds, LSI 3EX. ment were studied. Their personal, clinical, surgical, and laboratory details are listed in Table i . None was in congestive heart failure at the time of the preoperative studies, though all were severely incapacitated by breathlessness on exertion. Cases 2 and 6 were in sinus rhythm; the remainder were in atrial fibrillation. The chest radiographs and electrocardiographic findings were consistent with the clinical diagnoses and all patients were adjudged good surgical risks. Informed consent for the studies was obtained from all patients.
Design of investigation Measurements were made of the systemic arterial blood gas tensions, pH, free fatty acids, lactate, pyruvate, and glucose immediately before an insulin secretion test was performed; these measurements were made on the day before operation, during the first 12 hours after operation (Day I), and on the 2nd, 5th, 7th, 14th, and 28th postoperative days. The insulin secretion test was based on the potency of intravenous tolbutamide to release preformed insulin from the beta cells of the pancreas (Seltzer, I962) . The standardization, repeatability, and range of normal values of this test have been reported elsewhere (Saxton et al., 1970) . After the control venous sample, I g. tolbutamide was injected intravenously over io seconds. Further venous blood samples for the measurement of glucose and insulin were taken at I, 2, 5, 10, 15, 30, and 6o minutes. None of the patients complained of or showed any side-effects after the injection. The results ofthe insulin secretion tests were compared
Insulin secretion after open-heart surgery 7 ceived intravenous glucose therapy which prob-A The study was specifically designed not to ably accounts in part for the very high values of interfere in any way with the routine postopera-blood glucose observed at this time. Except for .,ive treatment of the patient. All but one patient the studies during the first 3 postoperative days (Case 2) received oxygen by face mask for some the insulin secretion tests were carried out in the days after operation (Table I) . During the first 3 morning 3 hours after a light meal. (Morley, Marks, and Dawson, I966) ; the coefficient of variation at io6 mg./ioo ml. was 5 per cent. Immunoreactive insulin was measured by the double-antibody radioimmunoassay method of Hales and Randle (I963), employing the reagents and oxoid membrane filter supplied by the Radio Chemical Centre at Amersham. The standards were based on crystalline bovine insulin using a calibration range o-50o F units/ml. The standard deviation of the assay method, calculated from the differences between 200 duplicate determinations in each of the concentration ranges 0-45,50-99, OO-i99, and greater than 200 [ . units/ml., was ± 3 3, ± 7*4, ± 97, and + 12-3 [L units/ml., respectively. All measurements were made in duplicate.
Measurements and calculations A quantitative measure of the 'total' insulin secretion was estimated by calculating the separate areas under the plasma curves for the first IO minutes and for the whole hour after the tolbutamide injection. Statistical analyses were based on orthodox methods (Fisher, I944) . ' 
Results
Studies before operation Before operation the systemic arterial blood gas tensions and pH were within the normal range in all 6 patients ( Table I ). The arterial free fatty acid I,level was within normal limits except in one patient (Case 2) in whom it was raised. The systemic arterial blood lactate was raised in one patient (Case i) before operation but was tWithin normal limits in the remainder. The arterial pyruvate level was raised in one 'patient (Case 2); in the remainder it was with<in normal limits. The The systemic arterial blood gas tensions and pH showed no consistent changes during the postoperative period due to the routine treatment with oxygen by face mask and correction of any fall in systemic arterial pH with parenteral sodium bicarbonate. The systemic arterial free fatty acid, lactate, and pyruvate measurements all showed a consistent pattern of change after operation. There was a considerable increase in all three variables during the immediate postoperative period, with a gradual return to their original preoperative level during the succeeding 28 days. The extent of the changes in these three variables correlated well with the clinical state of these patients (Table I) . The insulin secretion test likewise showed a close relation with the clinical state of the patient (Fig. i and (Sharma et al., 1970) . The mechanisms responsible for this suppression of insulin secretion are unknown, but a common factor in all of these patients is the low cardiac output.
In the experimental animal a large fall in cardiac output is invariably accompanied by a correspondingly large fall in splanchnic blood flow (Selkurt, Alexander, and Patterson, 1947; Selkurt and Brecher, 1956;  Levy, I958; Gregg, I962) . This fall in splanchnic and presumably pancreatic blood flow may prevent an adequate stimulus reaching the insulinsecreting beta cells. A second possible factor in the suppression of insulin secretion relates to the increased sympathetic drive and raised levels of circulating catecholamines that immediately follow a large fall in cardiac output. The catecholamines, and particularly adrenalin, have been shown not only to cause pathological changes specifically located in the beta cells of the pancreas (Loubatikres et al., 1965) but also to suppress insulin both in animals (Kris et al., I966; Hertelendy et al., I966; Altszuler et al., I967) and in man (Porte et al., 1966; Karam et al., I966; Majid et al., 1970 
